A decade ago, a celebrity cosmetics line was a licensing deal with a famous face on someone else’s product. Today it is an industry structure: founder-led brands built on social followings have sold stakes at valuations above a billion dollars, taken shelf space from century-old beauty houses, and turned the founder’s daily content into a marketing channel that legacy competitors cannot buy at any price. The celebrity beauty empire has become one of consumer business’s defining models — and, like all models, it is now mature enough to have failures worth studying.
The mechanics explain the rise. Customer acquisition is the beauty industry’s great expense; a founder with a hundred million followers acquires customers by posting. Product development cycles that took legacy brands two years compress into months of comment-section feedback. Retailers who once demanded slotting fees now court the brands whose launches crash websites. Industry trackers such as McKinsey, in its annual beauty reports, describe a market where founder brands and independents systematically outgrow the legacy portfolio — a shift investment banks have noticed: the beauty M&A calendar now runs on celebrity-founded targets.
Why Some Empires Crumble
The failures share an autopsy. Products that were merchandising rather than genuinely loved — weak formulas riding a famous name — die when the second purchase never comes. Founders who licensed their names without controlling quality discovered that a brand can out-argue its owner. And the attention engine cuts both ways: the same feed that builds the brand audits it, publicly, forever. The survivors look increasingly like real companies: professional chief executives, serious R&D, distribution beyond the founder’s own channels, and a brand story that could plausibly outlive its founder’s fame. Our entertainment-business desk covers the deals in our business coverage.
From Face to Institution
The Fragrance Test
Industry veterans use a private shortcut for judging celebrity brands: watch the second category. A founder who can extend from the hero product that made the brand — the lip kit, the skin tint — into adjacent categories without the audience revolting has built equity in trust, not just in a SKU. Most cannot; the graveyard of celebrity lines is filled with brands that were one product and one news cycle deep. The extensions that work share a discipline: they launch less often, at quality the founder can defend in a comment thread, into retailers who reorder. By that test the sector is sorting itself the way wine did — a few houses with genuine terroir, a long tail of labelled bottles. The famous name gets the first purchase. Everything in the business model after that is the same unglamorous work as every other brand’s, which is why so few survive it.
The exit market tells the sector’s fortune most honestly. Strategic buyers — the beauty conglomerates — pay their highest multiples not for fame but for the assets fame was supposed to build: repeat purchase rates, retail distribution, a customer file that answers emails. The celebrity brands that achieved nine-figure exits presented diligence rooms full of that unglamorous data; the ones that stalled presented follower counts. Private equity, having been burned by a few famous flame-outs, now underwrites these deals like any consumer brand, which is to say the fame is discounted to nearly zero and the fundamentals carry the valuation. The market has delivered its verdict: celebrity is a launch discount, not a business model.
The endgame being tested now is institutionalisation: whether a brand born as one person’s feed can become a house that hires its next face. Conglomerates buying in are betting yes — that the asset is the customer relationship and the product credibility, not only the celebrity. The founders who cash out richest will be those who built companies that happen to have famous founders, rather than followings that happen to sell lipstick. In beauty, as in every gold rush, the durable money is made by whoever builds the town.
